Investor AB has underperformed the S&P500 but remains a stable investment due to its diversified portfolio and buy-and-hold strategy. The company’s NAV has grown, with a 19% average annualized growth ...

Investor AB is a core holding in my portfolio due to its significant stakes in key Swedish industries and its low-risk, stable nature. Despite a recent 3% decline in NAV, Investor AB's diversified ...

Investor AB posted a lower shareholder return and swung to a net loss in the first quarter as its holdings in listed companies such as Saab generated weaker returns, hurt by market uncertainty. The ...

STOCKHOLM--Investor AB recorded a total shareholder return of 8% for the third quarter, turning positive after a negative return of 3% in the prior-year period. Investor AB's net asset value per share ...

Kepler Capital analyst Johan Sjoberg maintained a Buy rating on Investor AB (0NC6 – Research Report) on October 17 and set a price target of SEK342.00. The company’s shares closed last Thursday at ...

A unit of Investor AB, the investment firm controlled by Sweden’s Wallenberg family, will buy medical device maker Nova Biomedical in a $2.2 billion deal. The deal will see Nova Biomedical merge with ...

Investor AB is an investment company, which engages in long-term investment perspective. It operates through the following segments: Listed Companies, Patricia Industries, Investments in EQT, and ...